Top

Published in:

Open Access 01-06-2009 | Topic Paper

The present and future burden of urinary bladder cancer in the world

Authors: Martine Ploeg, Katja K. H. Aben, Lambertus A. Kiemeney

Published in: World Journal of Urology | Issue 3/2009

Abstract

Urinary bladder cancer (UBC) is a common disease worldwide. At any point in time 2.7 million people have a history of UBC. The incidence of UBC varies over the world with highest rates in developed communities. But the burden of UBC will increase in less developed areas of the world. These changes can be attributed to global changes in exposure to risk factors for UBC and growth and aging of the world population.

Garcia M, Jemal A, Ward EM, Center MM, Hao Y, Siegel RL, Thun MJ (2007) Global cancer facts and figs 2007. American Cancer Society, Atlanta

Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5.version 2.0. IARC Press, Lyon

Parkin DM (2008) The global burden of urinary bladder cancer. Scand J Urol Nephrol Suppl 218:12–20. doi:10.1080/03008880802285032 PubMedCrossRef

Crow P, Ritchie AW (2003) National and international variation in the registration of bladder cancer. BJU Int 92(6):563–566. doi:10.1046/j.1464-410X.2003.04421.x PubMedCrossRef

Zeegers MP, Tan FE, Dorant E, van Den Brandt PA (2000) The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 89(3):630–639. doi:10.1002/1097-0142(20000801)89:3<;630::AID-CNCR19>;3.0.CO;2-Q PubMedCrossRef

Felix AS, Soliman AS, Khaled H, Zaghloul MS, Banerjee M, El-Baradie M et al (2008) The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control 19(4):421–429. doi:10.1007/s10552-007-9104-7 PubMedCrossRef

Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ et al (2008) SEER cancer statistics review, 1975–2005. National Cancer Institute, Bethesda. http://seer.cancer.gov/csr/1975 2005/, based on November 2007 SEER data submission, posted to the SEER website

Kiemeney LA, Lemmers FA, Verhoeven RH, Aben KK, Honing C, de NJ et al (2008) The risk of cancer in the Netherlands. Ned Tijdschr Geneeskd 152(41):2233–2241PubMed

Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW (2008) Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44(10):1345–1389. doi:10.1016/j.ejca.2007.12.015 PubMedCrossRef

10.

Ferlay J, Randi G, Bosetti C, Levi F, Negri E, Boyle P et al (2008) Declining mortality from bladder cancer in Europe. BJU Int 101(1):11–19PubMed

11.

Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA et al (2005) Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97(19):1407–1427PubMedCrossRef

12.

Lopez A, Collishaw N, Piha T (1994) A descriptive model of the cigarette epidemic in developed countries. Tob Control 3:242–247. doi:10.1136/tc.3.3.242 CrossRef

13.

Mackay J, Eriksen M (2002) The tobacco atlas. World Health Organization, Geneva

14.

European Commission DHaCP2 Tobacco or health in the European Union: past, present and future. ASPECT Consortium

15.

Delclos GL, Lerner SP (2008) Occupational risk factors. Scand J Urol Nephrol Suppl 218:58–63. doi:10.1080/03008880802284423 PubMedCrossRef

16.

Kiemeney LA, Coebergh JW, Koper NP, van der Heijden LH, Pauwels RP, Schapers RF et al (1994) Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975–1989. Eur J Cancer 30A(8):1134–1137. doi:10.1016/0959-8049(94)90472-3 PubMedCrossRef

17.

Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22(12):1435–1448. doi:10.1097/00000478-199812000-00001 PubMedCrossRef

18.

Ezzati M, Lopez AD (2003) Estimates of global mortality attributable to smoking in 2000. Lancet 362(9387):847–852. doi:10.1016/S0140-6736(03)14338-3 PubMedCrossRef

19.

Ezzati M, Lopez AD (2003) Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tob Control 12(1):79–85. doi:10.1136/tc.12.1.79 PubMedCrossRef

20.

Shafey O, Dolwick S, Guindon GE (2003) Tobacco control country profiles. The 12th World Conference on Tobacco or Health

21.

Carlyle J, Collin J, Muggli ME, Hurt RD (2004) British American Tobacco and formula one motor racing. BMJ 329(7457):104–106. doi:10.1136/bmj.329.7457.104 PubMedCrossRef

22.

Dewhirst T, Hunter A (2002) Tobacco sponsorship of formula one and CART auto racing: tobacco brand exposure and enhanced symbolic imagery through co-sponsors’ third party advertising. Tob Control 11(2):146–150. doi:10.1136/tc.11.2.146 PubMedCrossRef

23.

El-Khoby T, Galal N, Fenwick A, Barakat R, El-Hawey A, Nooman Z et al (2000) The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates. Am J Trop Med Hyg 62:88–99PubMed

24.

Gouda I, Mokhtar N, Bilal D, El-Bolkainy T, El-Bolkainy NM (2007) Bilharziasis and bladder cancer: a time trend analysis of 9843 patients. J Egypt Natl Cancer Inst 19(2):71–76

25.

World Population Prospects (2007) The 2006 Revision. Exevutive Summary. United Nations, Department of Economic and Social Affairs

26.

Wu X, Ros MM, Gu J, Kiemeney L (2008) Epidemiology and genetic susceptibility to bladder cancer. BJU Int 102:1207–1215. doi:10.1111/j.1464-410X.2008.07961.x PubMedCrossRef

Title: The present and future burden of urinary bladder cancer in the world
Authors: Martine Ploeg
Katja K. H. Aben
Lambertus A. Kiemeney
Publication date: 01-06-2009
Publisher: Springer-Verlag
Published in: World Journal of Urology / Issue 3/2009
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-009-0383-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The present and future burden of urinary bladder cancer in the world

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2009

Experimental animal model and RNA interference: a promising association for bladder cancer research

Quantification of the survival benefit of early versus deferred cystectomy in high-risk non-muscle invasive bladder cancer (T1 G3)

Combination of BCG and interferon intravesical immunotherapy: an update

A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging

Application of new technology in bladder cancer diagnosis and treatment

Connexin45 expression in the human obstructed detrusor muscle